Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Abivax (AAVXF) Income from Continuing Operations (2024 - 2025)

Historic Income from Continuing Operations for Abivax (AAVXF) over the last 2 years, with Q3 2025 value amounting to -$179.3 million.

  • Abivax's Income from Continuing Operations fell 19559.75% to -$179.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.3 million, marking a year-over-year change of. This contributed to the annual value of -$188.3 million for FY2024, which is 1784.49% down from last year.
  • Abivax's Income from Continuing Operations amounted to -$179.3 million in Q3 2025, which was down 19559.75% from -$54.8 million recorded in Q2 2025.
  • Over the past 5 years, Abivax's Income from Continuing Operations peaked at -$41.8 million during Q2 2024, and registered a low of -$179.3 million during Q3 2025.